Here's why gold miner West African Resources Ltd shares rocketed 34% today

West African Resources Ltd (ASX:WAF) shares are on a tear today following news of a successful $21 million placement. Should you be investing?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Today has been yet another day of gains for shareholders of gold exploration company West African Resources Ltd (ASX: WAF). Today the share price rocketed higher by 34% bringing the year-to-date return to almost 500%.

Today's gain comes following news of a successful $21 million placement of 70 million shares at a price of 30 cents per share.

The funds raised from existing shareholders and leading institutional investors will mean the company can continue to rapidly progress its wholly-owned Tanlouka Gold Project and allow it to fully repay its debt facility with Macquarie Group Ltd (ASX: MQG) ahead of the maturity date.

Furthermore, the placement provides West African Resources with the capacity to accelerate exploration and resource drilling, as well as completion of the definitive feasibility study on its Burkina Faso gold project.

Much like fellow gold producers Resolute Mining Limited (ASX: RSG), St Barbara Ltd (ASX: SBM), and Newcrest Mining Limited (ASX: NCM), West African Resources shares have gone ballistic this year thanks in part to the incredible rise in the gold price.

But unlike those three, it has yet to pull any gold out of the ground this year. Whilst the company undoubtedly has excellent prospects and a strong balance sheet, I would be reluctant to make an investment at this stage. Especially considering the direction in which the price of gold takes from here is quite literally anybody's guess.

It may however be a good idea to add it to your watch list, as the results of its definitive feasibility study will no doubt make for interesting reading. Until then I would suggest focusing on other areas of the market with more predictable outlooks.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »